Distributed Outcome Routing for Cross-Trial Intelligence in Neurodegenerative Research

This article discusses the lack of a coordinated infrastructure to synthesize outcome intelligence across simultaneously active clinical trials in neurodegenerative disease research, leading to a high failure rate of drug candidates. It proposes a distributed outcome routing framework called Quadratic Intelligence Swarm (QIS) to address this isolation problem.

Details

The article examines the isolation problem across four major neurodegenerative disease areas: Alzheimer's, ALS, Parkinson's, and Huntington's. It highlights how signals like ARIA (amyloid-related imaging abnormalities) and APOE4 risk stratification in Alzheimer's trials accumulated across simultaneously running programs without a real-time routing layer to connect them. The QIS protocol is described as a distributed outcome routing architecture that allows each node to distill local observations into outcome packets and deposit them to a deterministic address defined by the semantic fingerprint of the problem. Other nodes with a similar problem can then query that address and synthesize the intelligence, scaling as N(N-1)/2 while compute scales at most O(log N). This approach does not require any patient data to leave the institutions and has no minimum cohort requirement, unlike federated learning.